To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives

N/ACompletedNCT01198444

Bayer11,884 enrolled

Overview

Adherence to the dosing scheme is the principal element of Combined Oral Contraceptives efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.

Study Type

OBSERVATIONAL

Enrollment

11,884

Conditions

Contraception

Interventions

EE/DRSP (Yasmin Product Family)DRUG

One tablet per day, orally, 21 tablets followed by 7 days, during three consecutive cycles.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients at the age of over 18 requiring contraception. The decisions would be made at the discretion of the attending physician. Exclusion Criteria: * According to official Summary of Product Characteristics (SmPC) contraindications.

Locations (1)

Unnamed facility

Many Locations, Poland

Outcomes

Primary Outcomes

The percentage of users showing noncompliant behaviors

Time frame: 3 consecutive cycles

Secondary Outcomes

The characteristics of noncompliant behavior

Time frame: 3 consecutive cycles

The relation between noncompliant behavior and selected factors

Time frame: 3 consecutive cycles

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.